Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Austin, Texas 78703


Purpose:

The purpose of this study is to evaluate the effectiveness of GW406381 (a COX-2 inhibitor) in treating the signs and symptoms of dental pain following third molar tooth extraction.


Study summary:

A Pivotal Phase III, Single Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Investigate the Efficacy and Safety of Single Oral Doses of 10mg, 25mg, 50mg, and 70mg GW406381 and 550mg Naproxen Sodium in Subjects With Pain Following Third Molar Tooth Extraction


Criteria:

Inclusion criteria: - Scheduled for outpatient surgical removal of at least two third molar teeth. Exclusion criteria: - Subjects who do not achieve moderate to severe pain. - Subjects who do not use acceptable contraception. - Additional medical criteria will be assessed by the investigator.


NCT ID:

NCT00114049


Primary Contact:

Study Director
GSK Clinical Trials, MD
GlaxoSmithKline


Backup Contact:

N/A


Location Contact:

Austin, Texas 78703
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 12, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.